3-(Boc-amino)azetidine Hydrochloride - CAS 217806-26-3
Catalog: |
BB017145 |
Product Name: |
3-(Boc-amino)azetidine Hydrochloride |
CAS: |
217806-26-3 |
Synonyms: |
N-(3-azetidinyl)carbamic acid tert-butyl ester;hydrochloride; tert-butyl N-(azetidin-3-yl)carbamate;hydrochloride |
IUPAC Name: | tert-butyl N-(azetidin-3-yl)carbamate;hydrochloride |
Description: | 3-(Boc-amino)azetidine Hydrochloride (CAS# 217806-26-3) is a useful research chemical. |
Molecular Weight: | 208.69 |
Molecular Formula: | C8H17ClN2O2 |
Canonical SMILES: | CC(C)(C)OC(=O)NC1CNC1.Cl |
InChI: | InChI=1S/C8H16N2O2.ClH/c1-8(2,3)12-7(11)10-6-4-9-5-6;/h6,9H,4-5H2,1-3H3,(H,10,11);1H |
InChI Key: | VLOLOLUAVFGUTD-UHFFFAOYSA-N |
Boiling Point: | 267.5 ℃ at 760 mmHg |
Density: | 1.06 g/cm3 |
Appearance: | Off-white crystalline powder |
MDL: | MFCD09839423 |
LogP: | 2.00460 |
Publication Number | Title | Priority Date |
WO-2021087181-A1 | Substituted pyrazole compounds as toll receptor inhibitors | 20191101 |
WO-2021065980-A1 | Bet degrader | 20190930 |
WO-2021027943-A1 | Pyrimidinopyridazinone derivative and medical use thereof | 20190814 |
US-2020397760-A1 | Methods of using rad51 inhibitors for treatment of pancreatic cancer | 20190621 |
WO-2020257752-A1 | Methods of using rad51 inhibitors for treatment of pancreatic cancer | 20190621 |
Complexity: | 170 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 2 |
Defined Atom Stereocenter Count: | 0 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 208.0978555 |
Formal Charge: | 0 |
Heavy Atom Count: | 13 |
Hydrogen Bond Acceptor Count: | 3 |
Hydrogen Bond Donor Count: | 3 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 208.0978555 |
Rotatable Bond Count: | 3 |
Topological Polar Surface Area: | 50.4 |
Undefined Atom Stereocenter Count: | 0 |
Undefined Bond Stereocenter Count: | 0 |
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Amines and Anilines
Customers Also Viewed
INDUSTRY LEADERS TRUST OUR PRODUCTS